Agilent Technologies, Inc.

New York Stock Exchange
Back to all articles
Bullish +75

Why Agilent Technologies Stock Triumphed on Thursday

📈 Agilent Technologies shares surged nearly 17% on Thursday following its quarterly earnings report.

💰 The company reported Q2 fiscal 2026 revenue of $1.83 billion, representing a 10% year-over-year increase.

📊 Non-GAAP net income rose 14% to $423 million, or $1.49 per share, beating analyst estimates.

🔬 All three reporting units delivered double-digit revenue growth, led by the Applied Markets Group at 14%.

🧬 The life sciences and diagnostics segment grew 12%, while CrossLab increased by 6% to $759 million.

📈 Management raised its full-year 2026 revenue guidance range to $7.39 billion–$7.49 billion.

💵 Adjusted net income projection was upgraded to $6.00–$6.10 per share from the previous estimate of $5.90–$6.04.

📉 Agilent beat consensus estimates for both revenue ($1.8B) and non-GAAP EPS ($1.41).

🚀 The Motley Fool Stock Advisor team did not include Agilent in their latest list of 10 best stocks to buy now.

📊 Stock Advisor highlights historical returns with Netflix and Nvidia as examples of past top picks.

⚠️ Investors are encouraged to consider the company's strong performance before making purchase decisions.

🤝 Eric Volkman and The Motley Fool disclose they hold no positions in the mentioned stocks.

Bullish Signals
  • Agilent Technologies shares surged nearly 17% on Thursday following a strong quarterly earnings report.
  • The company reported fiscal second quarter 2026 revenue of $1.83 billion, representing a 10% year-over-year increase.
  • Non-GAAP net income jumped 14% to $423 million, or $1.49 per share, significantly beating analyst estimates of $1.41 per share.
  • All three reporting units delivered revenue growth, with the Applied Markets Group leading at a 14% rise to $344 million.
  • The life sciences and diagnostics segment also showed robust performance with a 12% boost to $732 million.
  • Management raised full-year 2026 revenue guidance to a range of $7.39 billion to $7.49 billion, expanding the bottom end.
  • Adjusted net income projection was dramatically increased to $6 to $6.10 per share from the previous estimate of $5.90 to $6.04.
Risk Factors
  • The article explicitly states that Agilent Technologies was not included in The Motley Fool Stock Advisor's list of 10 best stocks to buy now, suggesting it may be overlooked by this specific investment strategy.
Full Analysis
Agilent Technologies (NYSE: A) shares surged nearly 17% on Thursday following the release of its fiscal second-quarter earnings report, which significantly exceeded analyst expectations. The company reported revenue of $1.83 billion, representing a 10% year-over-year increase, while non-GAAP net income rose 14% to $423 million, or $1.49 per share. These results beat the consensus estimates of $1.8 billion in revenue and $1.41 per share in adjusted net income, driven by growth across all three reporting units: Applied Markets Group (up 14%), Life Sciences and Diagnostics (up 12%), and CrossLab (up 6%). In response to the strong quarterly performance, management raised its full-year 2026 revenue guidance range to $7.39 billion to $7.49 billion from a previous outlook of $7.35 billion to $7.45 billion. Additionally, the company increased its adjusted net income projection for the year to between $6.00 and $6.10 per share, up from the prior estimate of $5.90 to $6.04 per share. The broad-based growth across segments and the upward revision of guidance have bolstered investor confidence in Agilent's future trajectory.